| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.97B | 10.57B | 8.97B | 6.49B | 4.94B | 4.20B |
| Gross Profit | 5.11B | 4.98B | 4.38B | 3.11B | 2.40B | 2.13B |
| EBITDA | 2.58B | 2.45B | 2.18B | 1.71B | 1.23B | 1.18B |
| Net Income | 1.47B | 1.36B | 1.23B | 1.01B | 779.78M | 760.81M |
Balance Sheet | ||||||
| Total Assets | 11.37B | 11.26B | 9.65B | 7.98B | 6.33B | 5.54B |
| Cash, Cash Equivalents and Short-Term Investments | 6.91B | 6.82B | 5.66B | 5.69B | 3.27B | 3.08B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 4.29B | 4.29B | 3.55B | 2.77B | 1.87B | 1.61B |
| Stockholders Equity | 7.08B | 6.97B | 6.11B | 5.21B | 4.45B | 3.93B |
Cash Flow | ||||||
| Free Cash Flow | 256.60M | 1.46B | 148.03M | 2.76B | 526.85M | 390.69M |
| Operating Cash Flow | 280.14M | 1.54B | 288.82M | 2.78B | 618.67M | 551.34M |
| Investing Cash Flow | -23.62M | 102.64M | 45.42M | -74.44M | -169.44M | -267.33M |
| Financing Cash Flow | -100.41M | -479.15M | -357.77M | -290.56M | -257.06M | -225.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥78.47B | 21.69 | ― | 2.02% | 13.52% | 7.75% | |
81 Outperform | ¥25.44B | 17.71 | ― | 2.50% | 16.70% | 22.23% | |
72 Outperform | ¥3.25B | 3.97 | ― | 2.04% | 12.86% | -63.06% | |
69 Neutral | ¥445.37B | 16.35 | 14.42% | 4.80% | 10.39% | 12.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | ¥41.08B | 20.82 | ― | ― | 13.25% | 1251.39% | |
56 Neutral | ¥72.37B | 12.85 | ― | 2.44% | 15.20% | -16.02% |